Wagener-Ryczek, S., Heydt, C., Süptitz, J., Michels, S., Falk, M., Alidousty, C., . . . Merkelbach-Bruse, S. (2020). Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors. BMC Cancer.
Stile di citazione ChicagoWagener-Ryczek, Svenja, et al. "Mutational Spectrum of Acquired Resistance to Reversible Versus Irreversible EGFR Tyrosine Kinase Inhibitors." BMC Cancer 2020.
Citazione MLAWagener-Ryczek, Svenja, et al. "Mutational Spectrum of Acquired Resistance to Reversible Versus Irreversible EGFR Tyrosine Kinase Inhibitors." BMC Cancer 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.